Chris Dall | News Reporter | CIDRAP NewsApr 15, 2020Scientists are sifting through which of dozens of serologic tests are going to be useful for assessing how many people have been exposed. But only one test has been reviewed by the FDA.
Antibody tests may hold clues to COVID-19 exposure, immunity—but it’s complicated
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Health leaders from multiple prior administrations sound alarm over CDC cuts
- COVID-19 may put patients at risk for other infections for at least 1 year
- COVID-19 re-infection doubles risk of long COVID in kids, young adults, data reveal
- Healthcare workers with chronic condition miss more days of work due to COVID than flu, data show